BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16472592)

  • 1. Bile acids induce ileal damage during experimental necrotizing enterocolitis.
    Halpern MD; Holubec H; Saunders TA; Dvorak K; Clark JA; Doelle SM; Ballatori N; Dvorak B
    Gastroenterology; 2006 Feb; 130(2):359-72. PubMed ID: 16472592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apical sodium-dependent bile acid transporter upregulation is associated with necrotizing enterocolitis.
    Halpern MD; Weitkamp JH; Mount Patrick SK; Dobrenen HJ; Khailova L; Correa H; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G623-31. PubMed ID: 20616306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does abnormal bile acid metabolism contribute to NEC?
    Halpern MD; Dvorak B
    Semin Perinatol; 2008 Apr; 32(2):114-21. PubMed ID: 18346535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis.
    Martin NA; Mount Patrick SK; Estrada TE; Frisk HA; Rogan DT; Dvorak B; Halpern MD
    PLoS One; 2011; 6(12):e27191. PubMed ID: 22162748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
    Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
    Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
    Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
    Dvorak B; Halpern MD; Holubec H; Williams CS; McWilliam DL; Dominguez JA; Stepankova R; Payne CM; McCuskey RS
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
    Halpern MD; Holubec H; Clark JA; Saunders TA; Williams CS; Dvorak K; Dvorak B
    Biol Neonate; 2006; 89(4):227-35. PubMed ID: 16319449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha.
    Halpern MD; Clark JA; Saunders TA; Doelle SM; Hosseini DM; Stagner AM; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G757-64. PubMed ID: 16269520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis.
    Cherrington NJ; Estrada TE; Frisk HA; Canet MJ; Hardwick RN; Dvorak B; Lux K; Halpern MD
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G48-56. PubMed ID: 23125159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary GD3 ganglioside reduces the incidence and severity of necrotizing enterocolitis by sustaining regulatory immune responses.
    Xu J; Anderson V; Schwarz SM
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):550-6. PubMed ID: 23783008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor.
    Halpern MD; Dominguez JA; Dvorakova K; Holubec H; Williams CS; Meza YG; Ruth MC; Dvorak B
    J Pediatr Gastroenterol Nutr; 2003 Jan; 36(1):126-33. PubMed ID: 12500008
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Calton CM; Carothers K; Ramamurthy S; Jagadish N; Phanindra B; Garcia A; Viswanathan VK; Halpern MD
    Am J Physiol Gastrointest Liver Physiol; 2024 Jan; 326(1):G25-G37. PubMed ID: 37933481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis.
    Weis VG; Deal AC; Mekkey G; Clouse C; Gaffley M; Whitaker E; Peeler CB; Weis JA; Schwartz MZ; Atala A
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G658-G674. PubMed ID: 33566727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model.
    Rentea RM; Liedel JL; Welak SR; Cassidy LD; Mayer AN; Pritchard KA; Oldham KT; Gourlay DM
    J Pediatr Surg; 2012 Jun; 47(6):1135-42. PubMed ID: 22703783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of bile acids in the pathogenesis of necrotizing enterocolitis.
    Yang J; Chen X; Liu T; Shi Y
    Life Sci; 2024 Jan; 336():122279. PubMed ID: 37995935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model.
    Dvorak B; Halpern MD; Holubec H; Dvorakova K; Dominguez JA; Williams CS; Meza YG; Kozakova H; McCuskey RS
    Pediatr Res; 2003 Mar; 53(3):426-33. PubMed ID: 12595590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased development of necrotizing enterocolitis in IL-18-deficient mice.
    Halpern MD; Khailova L; Molla-Hosseini D; Arganbright K; Reynolds C; Yajima M; Hoshiba J; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G20-6. PubMed ID: 17947451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin alleviates necrotizing enterocolitis by reducing bile acid levels through the SIRT1/FXR signalling axis.
    Lai J; Li F; Li H; Huang R; Ma F; Gu X; Cai Y; Huang D; Li S; Xiao S; Hao H
    Int Immunopharmacol; 2024 Feb; 128():111360. PubMed ID: 38176339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.